Is Scottish Mortgage the next big success story?
Despite facing setbacks, the Scottish Mortgage Trust bounces back, making it a top fund pick for investors.
It’s been a roller coaster ride for shareholders of the Scottish Mortgage Investment Trust (LSE: SMT), the £11billion giant of the investment-trust sector.
The share price trebled to £15 in the two years to late 2021, then fell by 60% to a low of £6 in the next 18 months. It then climbed back to more than £8 at the end of 2023, before slipping to 750p in January. The price went from a premium to net asset value (NAV) to a 20% discount but now trades at an 11% discount.
Investors swung from adulation of its focused portfolio of high-growth listed and unlisted stocks (the top-ten holdings account for 45% of the portfolio, 30% of which is unlisted) to deep scepticism. But they now appear to be shifting back to optimism again.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Winterflood Securities rates the shares a “buy” and includes SMT in its tips for 2024.
“The managers have displayed a sensible focus on a range of structural growth trends... Moreover, the private-equity allocation has been used to good effect in gaining access to positions that competing funds simply cannot offer,” writes Shavar Halberstadt.
Inevitably, the share prices of listed holdings are volatile. By mid-January, Nvidia, the fourth-largest holding at 5.1% of the portfolio, had risen by 14% on strong results, while Tesla, the sixth-largest holding at 4.5%, was down by 11.5% as demand for electric vehicles appears to be weakening.
Potential buyers are concerned about obsolescence resulting in poor second-hand values, as the technology is fast improving and infrastructure has not kept pace with demand.
These should be temporary problems. The confidence of the managers, Tom Slater and Lawrence Burns has not faltered. They accept there have been mistakes and some investments haven’t worked out, but the Baillie Gifford thesis is that a few big winners will always compensate for the disappointments.
A sliding share price does not necessarily correspond with a disappointing outlook. For example, the stock of Moderna, 4.4% of the portfolio, has fallen from $450 in late 2021 to $102 as demand for its Covid vaccine has disappeared.
The vaccine emerged from its mRNA platform, of which it was an unexpected by-product. “In the next five years,” says CEO Stéphane Bancel, “people will have forgotten what we did in the pandemic and know us primarily for our work in cancer care – prevention and early treatment.”
Moderna’s appeal lies in “the breadth of what they can do with the technology”, says Tom Slater. “If you can prove that it works in one setting, it will substantially improve the chances of success in lots of other settings. There are huge areas of unmet clinical need… that their technology will be able to address.”
Joby Aviation is a smaller holding but is bringing the dream of flying cars to reality with electric, vertical take-off aircraft that it hopes will become “the Uber of the skies”. “It’s really exciting to see this idea from science fiction become a commercial reality,” says Slater.
“We will provide quick, safe, quiet, green transportation in many cities around the world,” says Paul Sciarra, executive chairman.
Elon Musk’s SpaceX, 3.7% of the portfolio, has reduced the cost of rocket launches to take satellites into space by 97% through the use of reusable rockets. Its Starlink network provides high-speed global internet in otherwise inaccessible locations. Another holding, Zipline, uses drones for fast and accurate delivery to firms and consumers, while Swedish-based Northvolt (3.2%) is building “the world’s greenest batteries”.
In the past two years, most of SMT’s investments have continued to progress, either growing revenue, developing their business base or progressing towards commercialisation.
Investors’ sentiment may have gone from starry-eyed optimism to extreme scepticism, but none of the major holdings are short of capital. Their growing success should prove highly profitable for SMT’s shareholders.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
8 of the best properties for sale with indoor swimming pools
The best properties for sale with indoor swimming pools – from an award-winning contemporary house in East Sussex, to a converted barn in Hampshire
By Natasha Langan Published
-
Chinese stocks slump on first trading day of 2025
Chinese stocks suffered in the new year from their worst first day of trading since 2016, despite a state stimulus package
By Alex Rankine Published
-
Why Wise could be worth a lot more than its share price implies
Foreign-exchange transfer service Wise has the potential to become the Amazon of its sector – here's why you should consider buying this stock now
By Jamie Ward Published
-
Can The Gym Group pump up your portfolio?
Gym Group was one of the best UK small-cap stocks in 2024 and will beef up your profits this New Year
By Rupert Hargreaves Published
-
MoneyWeek's five predictions for investors in 2025
MoneyWeek's City columnist gazes into his crystal ball and sees five unexpected events in store for investors in 2025
By Matthew Lynn Published
-
How buy-and-build stocks deliver strong returns
Bunzl, DCC and Diploma became successful through buy-and-build – rolling up dozens of unglamorous businesses. How does it work and what makes it successful?
By Jamie Ward Published
-
Why are Reits still out of favour?
The dividend yield on UK Reits suggests that this long-term property proxy offers unusually attractive value
By Cris Sholto Heaton Published
-
Singapore Technologies Engineering shows strong growth
Singapore Technologies Engineering offers diversification, improving profitability and income
By Dr Mike Tubbs Published
-
Baillie Gifford trusts gain from SpaceX valuation – what does it mean for investors?
Baillie Gifford's funds have gained from Elon Musk’s relationship with US president-elect Donald Trump. Are private investments really a safe bet?
By Rupert Hargreaves Published
-
Has RIT Capital fallen out of favour?
RIT Capital saw its discount soar amid weak returns, and investors remain sceptical of a turnaround
By Max King Published